Capitolis Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding SGEN
BBA
Capitolis Advisors's SGEN Position: Q1 2022 in Review
Capitolis Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q1 2022, closing a stake of 8,895 shares — an estimated $1.38M sold.
Capitolis Advisors first reported a position in SGEN in Q4 2021 and held it in 1 quarter. The position peaked at $1.38M in Q4 2021. 506 funds tracked by Wall St. Rank hold SGEN as of Q1 2022.
- Capitolis Advisors reported no remaining Seagen Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- Capitolis Advisors sold 8,895 Seagen Inc. Common Stock shares in Q1 2022, an estimated $1.38M.
- Capitolis Advisors first reported a position in Seagen Inc. Common Stock in Q4 2021 and held it in 1 quarter.
- Capitolis Advisors's Seagen Inc. Common Stock position peaked at $1.38M in Q4 2021.
- 506 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2022.
Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.